A foot found in the Delaware River was identified as belonging to a woman who went missing in Allentown in 2014, thanks to a ...

Human remains found in New Jersey in 2017 have finally been identified as a Pennsylvania woman who went missing more than a ...

Topline data were announced from a phase 2/3 trial evaluating immune globulin intravenous (human) in patients with post-polio syndrome.

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Students from Ramapo College helped the New Jersey State Police solve a decade-old cold case by identifying the remains of ...

Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial ...

Just like DNA strands, no two cold cases are alike. “I’ve always been interested in both genetics and family history,” said ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Early this year, Kamada announced that it expects continued double-digit growth – all while maintaining profitability – for ...

Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...